Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
LOS ANGELES and AMSTERDAM, April 30, 2024 -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. , a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a...